Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MCD | SCHW |
|---|---|---|
| Price | $239.64 | $99.44 |
| Change today | ▲ 0.55% | ▼ 0.06% |
| Market cap | $169.58B | $171.97B |
| Return, 3 months | -11.9% | +9.1% |
| Return, year to date | -20.1% | +0.5% |
| Return, 1 year | -19.2% | +9.0% |
| P/E (TTM) | 19.5 | 18.1 |
| P/B | -165.7 | 3.9 |
| P/E percentile vs own 5y | 0th | 20th |
| Dividend yield | 3.07% | 1.19% |
| Revenue growth (YoY, latest qtr) | +3.8% | +20.9% |
| Net profit growth (YoY) | +4.8% | +31.7% |
| Gross margin | 57.4% | – |
| Operating margin | 45.7% | – |
| Net margin | 31.7% | 37.4% |
| Return on equity | – | 22.4% |
| Analyst target vs. price | +30.4% | +25.4% |
| Analyst buy share | 58% | 82% |
| RSI (14) | 27 | 36 |
| 30-day volatility | 21.6% | 27.6% |
| Max drawdown, 1 year | -28.4% | -19.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.